ArticleMaterials today. Bio2026
TZM Mo alloy behaves superb as biodegradable metal for bone-fracture healing intramedullary nail implant.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone fracture repair, particularly assisted by load-bearing implants, faces tough clinical challenges, necessitating novel biomaterials that are mechanically strong, biocompatible and biodegradable to achieve effective healing. Metallic molybdenum (Mo) has shown promise in this regard, whereas little has been done with considering its alloys that are more advantageous on many aspects over its pure counterpart. Herein, we demonstrate that the TZM Mo alloy (namely Titanium-Zirconium-Molybdenum, also Mo-Ti-Zr) performed superb efficacy in the repair of rat femoral fractures with its intramedullary nails (IMNs) prototype product even as compared with pure Mo. The TZM alloy had superior mechanical strength and more uniform degradation than Mo, meeting the requirements for next-generation biodegradable IMNs. Moreover, the
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.